17:27 EST ALX Oncology (ALXO) files $364.12M mixed securities shelf See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for ...

Piper Sandler raised the firm’s price target on ALX Oncology (ALXO) to $9 from $8 and keeps an Overweight rating on the shares following the company’s R&D Day, where management detailed a more ...

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for ...